Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01722916 · ClinicalTrials.gov registry record · Early Phase 1
Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase
A Early Phase 1 study of Drug Safety, sponsored by Northwestern University.
- Active
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01722916: Active Early Phase 1 study of Drug Safety, sponsored by Northwestern University.
NCT01722916 is a Early Phase 1 study of Drug Safety that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 5 participants, below the 103-participant average among 4 other Drug Safety trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01722916, a Early Phase 1 study of Drug Safety, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.
Conditions Studied
Interventions
- DRUG Hyaluronidase
Study Locations (1)
Illinois
- Northwestern University Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-10 |
| Est. Completion | 2025-12 |
| Phase | Early Phase 1 |
What the registry record for NCT01722916 still lists
NCT01722916 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 103-participant average among 4 other Drug Safety trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Drug Safety appearing as the primary indexed condition, and to 1 intervention - of which Hyaluronidase is the first listed.
NCT01722916 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01722916 about?
NCT01722916 is a clinical study titled "Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase". The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.
What is the current status of trial NCT01722916?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2012-10. Estimated completion is 2025-12.
What conditions does trial NCT01722916 study?
This clinical trial studies the following conditions: Drug Safety.
What interventions are being tested in trial NCT01722916?
The interventions under investigation include: Hyaluronidase (DRUG).
Who is sponsoring clinical trial NCT01722916?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01722916 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Safety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography
COMPLETED · Phase 4
-
Safety and Pharmacokinetics Study of CARD-024 in Healthy Subjects
COMPLETED · Phase 1
-
Clinical Safety of a Novel Milk Protein Peptide
COMPLETED · Phase 1
-
Ascending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia